Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis ...
TRAILBLAZER-2, a Phase 3 study, has enrolled 1,600 participants. Prescreening with plasma p-tau-181 helped select people with both amyloid and tau pathology. A secondary prevention trial, ...
LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global three-phase separator market in the oil and gas industry report. This research report also lists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results